Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Milestone Scientific
MLSS
Milestone Scientific
Healthcare Cost Pressures Will Limit Adoption Yet Progress Will Emerge
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
17 Aug 25
Updated
17 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$1.25
52.2% undervalued
intrinsic discount
17 Aug
US$0.60
Loading
1Y
-40.1%
7D
-0.6%
Author's Valuation
US$1.3
52.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$1.3
52.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-9m
18m
2014
2017
2020
2023
2025
2026
2028
Revenue US$18.0m
Earnings US$2.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
15.87%
Medical Equipment revenue growth rate
0.43%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.52%
Calculation
US$2.24m
Earnings '28
x
55.46x
PE Ratio '28
=
US$124.30m
Market Cap '28
US$124.30m
Market Cap '28
/
80.59m
No. shares '28
=
US$1.54
Share Price '28
US$1.54
Share Price '28
Discounted to 2025 @ 7.52% p.a.
=
US$1.24
Fair Value '25
